This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. They were all treated with pulse therapy of methyl prednisolone and broad-spectrum antibiotics systemically. Topically treated with Chloramphenicol-Dexamethasone combination eye ointment, cyclosporine 0.05% eye drops 4 times a day, carboxymethylcellulose 1% eye drops 6-8 times a day, and hypromellose 0.3% Gel form 3-4 times a day along with swiping of the conjunctival membranes every alternate day. They were discharged after the resolution of the acute phase.
On follow-up, the best-corrected vision ranged from counting fingers 3 meters to 6/6, depending on the corneal involvement. Five of them had keratoconjunctiva sicca with persistent corneal epithelial erosions. Two of them had persistent corneal epithelial defects. Three patients with severe persistent corneal erosions and epithelial defects (including Case 5) required rigorous treatment with gel form of hypromellose 0.3%, topical cyclosporine 0.05% eye drops with amniotic membrane graft transplantation (AMT) to enhance healing. Trichiatic lashes seen in five of them were epilated periodically. Entropion and symblepharon were seen in five, and two of the patients, respectively, were managed conservatively. The first case had lacrimal punctual atresia, which was managed conservatively. The second case has conjunctival retention cyst which resolved with continued application of cyclosporine 0.05% eye drops. Forniceal reformation with AMT was done in fornecial shortening to inhibit further fibrotic reaction in Case 6. Photophobia due to persistent epithelial erosions was the major debilitating complaint at follow-up.
The skin lesions healed with supportive treatment after 3 weeks [ Figure 2 ].
discussion
Epidermal necrolysis encompasses SJS (<10% of the skin affected), Lyell syndrome (TEN, with ≥30% of the skin affected) and an overlap syndrome (10%-29% of the skin affected). These rare diseases are caused, in 85% of cases, by pharmacological treatments, with symptoms occurring 4-28 days after treatment initiation. The diagnosis is clinical. Mortality is 20%-25% during the acute phase, and almost all patients display disabling sequelae (mostly ocular impairment and psychological distress). [1] [2] [3] The triggering factors in our patients were mefenamic acid and phenytoin, which are established trigger agents. Two patients of the four TEN patients triggered by phenytoin were found to be HLA B*1502 positive suggesting genetic predisposition and altered drug metabolism. Others could not undergo HLA typing because of financial limitations. [4] [5] [6] All our patients showed moderate-severe lid and conjunctival inflammation with membrane formation and corneal erosions. They have been classified as described by Power et al. depending on their degree of lid, conjunctival and corneal involvement and graded as proposed by Sotozono et al. according to the degree of ocular surface inflammation and epithelial necrosis or apoptosis. [7, 8] Four patients were graded as severe because of painful nonhealing persistent epithelial defects.
All responded to the topical regimen. However, the three patients with severe keratoconjunctivitis sicca and persistent corneal lesions required AMT and had a vision of counting fingers postsurgery but were relieved of pain. Forniceal reformation with AMT was done for forniceal shortening in Case 6 to relieve painful eye movements and corneal erosions. The other patients with symblepharon and entropion have been managed conservatively on follow-ups. The final visual outcome ranged from counting fingers three meters to 6/6. The skin lesions in all the patients healed irrespective of the status of ocular lesions [ Table 1 ].
Photophobia was observed to be more severe in patients with total body surface area involvement more than 80% and severe systemic involvement, which inspired us to start our study but, because of the rare occurrence of the disease and very small subject size, we were unable to establish any causal-effect hypothesis [ Table 2 ]. conclusion TEN is more than just a hypersensitivity reaction and dermatological entity. The ocular involvement with cicatrizing sequelae jeopardizes the quality of life grievously. The ocular involvement can occur at any stage of the disease, so require close follow-up and prolonged maintenance treatment to reduce the degree of keratoconjunctiva sicca and photophobia. All TEN patients require a team effort for recovery and have to be counseled for frequent follow-ups to maintain a satisfactory quality of life in future. 
